Send to a Friend Font Size: Increase Decrease

Broadfin Capital

Broadfin Capital's Portfolio

Ticker	# of Shares	Price	Value
	5,574,366	$195.32	$1,088,785,168
	2,707,851	$195.32	$528,897,458
	2,000,000	$195.32	$390,640,000
	1,839,372	$195.32	$359,266,140
SPY	440,000	$741.75	$326,370,000
	1,236,368	$195.32	$241,487,398
IWM	800,000	$292.95	$234,360,000
	1,029,012	$195.32	$200,986,624
	1,003,099	$195.32	$195,925,297
	721,073	$195.32	$140,839,979
View Additional Portfolio Information »

Broadfin Capital

Login to help us fill in information about this entity.

Form SC 13G/A Lion Biotechnologies, Filed by: Broadfin Capital, LLC Feb 10, 2017 04:47PM

Lion Biotechnologies Announces Second Quarter 2016 Financial Results Aug 8, 2016 04:30PM

Unusual 11 Mid-Day Movers 6/3: (LBIO) (EBIO) (JVA) Higher; (GSAT) (GOGO) (IMMU) Lower Jun 3, 2016 12:55PM

Lion Biotechnologies (LBIO) Names Maria Fardis, Ph.D., as CEO; Board Appointments Announced Jun 3, 2016 09:36AM

Lion Biotechnologies Appoints Maria Fardis, Ph.D., as CEO Jun 3, 2016 09:34AM

Feb 11, 2016 04:42PM Form SC 13G Lion Biotechnologies, Filed by: Broadfin Capital, LLC